ARTICLE | Company News
Sonus, Daiichi Pharmaceutical deal
September 3, 1996 7:00 AM UTC
SNUS will receive a $3 million milestone payment from Daiichi this month for completing a Phase II trial of its EchoGen fluorocarbon-based ultrasound contrast agent for myocardial perfusion. SNUS pres...